ly 255283 has been researched along with thromboxane a2 in 1 studies
Studies (ly 255283) | Trials (ly 255283) | Recent Studies (post-2010) (ly 255283) | Studies (thromboxane a2) | Trials (thromboxane a2) | Recent Studies (post-2010) (thromboxane a2) |
---|---|---|---|---|---|
54 | 0 | 15 | 5,617 | 224 | 429 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cockerham, SL; Fleisch, JH; Goodson, T; Herron, DK; Roman, CR; Saussy, DL; Silbaugh, SA; Spaethe, SM; Stengel, PW | 1 |
1 other study(ies) available for ly 255283 and thromboxane a2
Article | Year |
---|---|
Pulmonary actions of LY255283, a leukotriene B4 receptor antagonist.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Airway Obstruction; Analgesics; Animals; Dinoprostone; Guinea Pigs; In Vitro Techniques; Leukotriene B4; Lung; Lung Volume Measurements; Male; Membranes; Muscle Contraction; Prostaglandin Endoperoxides, Synthetic; Pulmonary Gas Exchange; Radioligand Assay; Receptors, Immunologic; Receptors, Leukotriene B4; Tetrazoles; Thromboxane A2 | 1992 |